Information  X 
Enter a valid email address

Astrazeneca PLC OrdShs USD0.25 (AZN)

Related News

30-Oct-2019 08:00 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 7800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Oct-2019 10:50 AM

Broker Forecast - Kepler Cheuvreux issues a broker note on AstraZeneca PLC

Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8000p (from 7700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Oct-2019 09:40 AM

Broker Forecast - UBS issues a broker note on AstraZeneca PLC

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5800p (from 5700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Oct-2019 08:40 AM

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today upgrades its investment rating on AstraZeneca PLC (LON:AZN) to buy (from hold). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
24-Oct-2019 07:45 AM

AstraZeneca upgrades sales guidance following 16% growth in Q3

AstraZeneca upgraded its guidance on product sales following a 16% rise in the third quarter of the year, led by growth in its portfolio of cancer drugs. Product sales at constant currency were now expected to increase by a low to mid-teens percentage;
15-Oct-2019 09:20 AM

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC

Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6700p (from 6550p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
23-Sep-2019 07:19 AM

AstraZeneca sees Qtrilemt recommended for approval in EU

AstraZeneca has announced that Qtrilment has been recommended for marketing authorisation in the EU by the Committe for Medicinal Products for Human Use (CHMP). The CHMP recommended this for Qtrilmet to improve glycaemic control when metformin with or wi
18-Sep-2019 07:16 AM

AstraZeneca amends collaboration with Ironwood

AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals in China mainland, China Hong Kong, and China Macau for Linzess. This new agreement gives AstraZeneca full responsibility for developing, manufacturing, and commercialising
13-Sep-2019 10:10 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8200p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Sep-2019 08:10 AM

Broker Forecast - Citigroup issues a broker note on AstraZeneca PLC

Citigroup today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 10000p (from 7000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
09-Sep-2019 09:50 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7800p (from 7600p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Sep-2019 12:40 PM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8000p (from 7800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-Sep-2019 08:40 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7600p (from 7200p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
16-Aug-2019 08:30 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7800p (from 7600p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-Aug-2019 09:40 AM

Broker Forecast - UBS issues a broker note on AstraZeneca PLC

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5700p (from 5400p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Aug-2019 09:10 AM

Broker Forecast - Goldman Sachs issues a broker note on AstraZeneca PLC

Goldman Sachs today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5500p (from 5000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Jul-2019 08:30 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7200p (from 6900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
26-Jul-2019 09:50 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7600p (from 7500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Jul-2019 07:31 AM

AstraZeneca lifts product sales guidance amid stronger H1

AstraZeneca upgraded its product sales guidance as an acceleration in second-quarter sales bolstered its first-half performance. Product sales in 2019 were now expected to increase by a low double-digit percentage; the prior guidance was for a high sin
08-Jul-2019 09:10 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6900p (from 6800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
24-May-2019 09:10 AM

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC

Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 6350p (from 6400p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
24-May-2019 09:00 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7200p (from 7000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
10-May-2019 08:10 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 6800p (from 6900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-May-2019 10:50 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6900p (from 6800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Apr-2019 10:30 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 6800p (from 6900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t